124 related articles for article (PubMed ID: 22285335)
1. Clinical features and outcomes of head and neck castleman disease.
Chen YF; Zhang WD; Sun CZ; Ouyang D; Chen WK; Luo RZ; Wu MW
J Oral Maxillofac Surg; 2012 Oct; 70(10):2466-79. PubMed ID: 22285335
[TBL] [Abstract][Full Text] [Related]
2. Cervical unicentric Castleman disease presenting as a neck mass: case report and review of the literature.
Liang J; Newman JG; Frank DM; Chalian AA
Ear Nose Throat J; 2009 May; 88(5):E8. PubMed ID: 19444782
[TBL] [Abstract][Full Text] [Related]
3. Castleman disease in the pediatric neck: a literature review.
Rabinowitz MR; Levi J; Conard K; Shah UK
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1028-36. PubMed ID: 23459702
[TBL] [Abstract][Full Text] [Related]
4. Castleman's disease in the head and neck region: Meta-analysis of reported cases in Taiwan and literature review.
Lin CY; Chang YL
J Formos Med Assoc; 2010 Dec; 109(12):913-20. PubMed ID: 21195890
[TBL] [Abstract][Full Text] [Related]
5. Development of a Hodgkin disease tumor in the neck of a patient who previously had undergone complete excision of a hyaline-vascular Castleman disease neck mass.
Unsal Tuna EE; Ozbek C; Arda N; Ilkdogan E; Dere H; Ozdem C
Ear Nose Throat J; 2010 Apr; 89(4):E20-3. PubMed ID: 20397132
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcome of superficial and deep Castleman disease.
Chen CH; Liu HC; Tung KY; Lee JJ; Liu CL; Liu TP
ANZ J Surg; 2007 May; 77(5):339-43. PubMed ID: 17497971
[TBL] [Abstract][Full Text] [Related]
7. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
8. Castleman disease of the hyaline-vascular type confined to the kidney.
Mah NA; Peretsman SJ; Teigland CM; Banks PM
Am J Clin Pathol; 2007 Mar; 127(3):465-8. PubMed ID: 17276946
[TBL] [Abstract][Full Text] [Related]
9. Interfollicular Hodgkin's lymphoma and Castleman's disease.
Zanetto U; Pagani FP; Pérez C
Histopathology; 2006 Feb; 48(3):317-9. PubMed ID: 16430484
[No Abstract] [Full Text] [Related]
10. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
11. Solitary intra-abdominal Castleman's disease, hyaline vascular type: case report.
Al-Saleh N; Itty P; Kukawski P; Al-Khaldi K
Gulf J Oncolog; 2010 Jan; (7):53-6. PubMed ID: 20164010
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and surgical treatment of Castleman's disease].
Ma SH; Liu QJ; Zhang YC; Yang R
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1118-21. PubMed ID: 21609596
[TBL] [Abstract][Full Text] [Related]
13. Castleman's disease as an uncommon cause of a neck mass.
Beraldo S; Altavilla G; Bernante P; Pelizzo MR
Acta Otolaryngol; 2006 Jan; 126(1):108-11. PubMed ID: 16308264
[TBL] [Abstract][Full Text] [Related]
14. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
15. Localized peripancreatic plasma cell Castleman disease.
Charalabopoulos A; Misiakos EP; Foukas P; Tsapralis D; Charalampopoulos A; Liakakos T; Macheras A
Am J Surg; 2010 May; 199(5):e51-3. PubMed ID: 20079482
[TBL] [Abstract][Full Text] [Related]
16. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
17. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis.
Menke DM; Camoriano JK; Banks PM
Mod Pathol; 1992 Sep; 5(5):525-30. PubMed ID: 1285353
[TBL] [Abstract][Full Text] [Related]
18. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
20. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
